13G FILING

Company

Evofem Biosciences, Inc.

Filed

February 11, 2015

Accession Number

0001540796-15-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →